Patent · US Active

S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

US10449166B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

ACTIMED THERAPEUTICS LIMITED · GB

Inventors

Andrew J. S. Coats · Melbourne, AU
Stefan Anker · Berlin, DE
Jochen Springer · Falkensee, DE

Key dates

Filing date	Mar 14, 2014
Grant date	Oct 22, 2019
Priority date	—
Expiry date	Mar 14, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.